Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New Products In Brief

This article was originally published in The Gray Sheet

Executive Summary

Debuts include OptiMedica’s Catalys laser system for cataract surgery, Quest’s cervical cancer test and NeuroSigma’s Monarch external trigeminal nerve stimulation (eTNS) system for epilepsy and major depressive disorder.

You may also be interested in...

People Briefs: Covidien CFO To Retire; Appointments At ConvaTec, Metamark, NeuroSigma, Uroplasty

Covidien Chief Financial Officer Charles Dockendorff announces retirement. ConvaTec, Metamark, NeuroSigma and Uroplasty appoint executives. More people briefs.

HeartWare Adds Synergy Circulatory Support System With $30 Mil. CircuLite Buy

The acquisition could significantly expand the targeted market base for HeartWare, but first the company will need to re-launch CircuLite’s Synergy in Europe, which experiences a design problem the first time around.

Research In Brief

Deep brain stimulation may help anorexia patients. CircuLite set to start clinical trial of Synergy mini-pump. More research briefs.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts